Literature DB >> 8514375

Choice of bacteria in animal models of sepsis.

A S Cross1, S M Opal, J C Sadoff, P Gemski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8514375      PMCID： PMC280916          DOI： 10.1128/iai.61.7.2741-2747.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  69 in total

1.  The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement.

Authors:  C J Howard; A A Glynn
Journal:  Immunology       Date:  1971-05       Impact factor: 7.397

2.  The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits.

Authors:  J C Mathison; R J Ulevitch
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

3.  Plasma tumor necrosis factor levels in patients with presumed sepsis. Results in those treated with antilipid A antibody vs placebo.

Authors:  M A de Groote; M A Martin; P Densen; M A Pfaller; R P Wenzel
Journal:  JAMA       Date:  1989-07-14       Impact factor: 56.272

4.  Quantitative relationship between capsular content and killing of K1-encapsulated Escherichia coli.

Authors:  C Vermeulen; A Cross; W R Byrne; W Zollinger
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

5.  Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.

Authors:  G Zanetti; D Heumann; J Gérain; J Kohler; P Abbet; C Barras; R Lucas; M P Glauser; J D Baumgartner
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

6.  Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.

Authors:  S M Opal; A S Cross; J C Sadoff; H H Collins; N M Kelly; G H Victor; J E Palardy; M W Bodmer
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

7.  Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection.

Authors:  A Nakane; T Minagawa; K Kato
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

8.  Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis.

Authors:  G J Bagby; K J Plessala; L A Wilson; J J Thompson; S Nelson
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

9.  Cytokine appearance in human endotoxemia and primate bacteremia.

Authors:  D G Hesse; K J Tracey; Y Fong; K R Manogue; M A Palladino; A Cerami; G T Shires; S F Lowry
Journal:  Surg Gynecol Obstet       Date:  1988-02

10.  Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.

Authors:  G D Martich; R L Danner; M Ceska; A F Suffredini
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307
View more
  45 in total

1.  Gram-negative, but not Gram-positive, bacteria elicit strong PGE2 production in human monocytes.

Authors:  Christina C Hessle; Bengt Andersson; Agnes E Wold
Journal:  Inflammation       Date:  2003-12       Impact factor: 4.092

2.  Turning down the heat: the potential role of RIP140 in inflammation.

Authors:  Wilbur H Chen
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

Review 3.  Differential Paradigms in Animal Models of Sepsis.

Authors:  S Manoj Kumar Kingsley; B Vishnu Bhat
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

4.  Interleukin-10 protects against lethality of intra-abdominal infection and sepsis.

Authors:  A J Rongione; A M Kusske; K Kwan; S W Ashley; H A Reber; D W McFadden
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

Review 5.  The difficulties of clinical trials evaluating therapeutic agents in patients with severe sepsis.

Authors:  T C Hall; D K Bilku; D Al-Leswas; C Horst; A R Dennison
Journal:  Ir J Med Sci       Date:  2011-11-08       Impact factor: 1.568

Review 6.  Modeling sepsis in the laboratory: merging sound science with animal well-being.

Authors:  Jean A Nemzek; Kelly M S Hugunin; Mark R Opp
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

7.  Murine responses to endotoxin: another dirty little secret?

Authors:  Robert S Munford
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

8.  Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; M Poppelier; K Kraaijeveld; J Verhoef
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Roles of neutrophils in the regulation of the extent of human inflammation through delivery of IL-1 and clearance of chemokines.

Authors:  Alexander Basran; Maisha Jabeen; Lynne Bingle; Clare A Stokes; David H Dockrell; Moira K B Whyte; Sarah R Walmsley; Kathryn R Higgins; Stefanie N Vogel; Heather L Wilson; Lynne R Prince; Elizabeth C Prestwich; Ruth A Sabroe; Lisa C Parker; Ian Sabroe
Journal:  J Leukoc Biol       Date:  2012-08-17       Impact factor: 4.962

10.  Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; W Hustinx; J Schellekens; K Kraaijeveld; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.